Interactions between eotaxin and interleukin-5 in the chemotaxis of primed and non-primed human eosinophils

European Journal of Pharmacology

Volumn 566, Issue 1-3, 2007, Pages 200-205

  Costa, Gislaine G ^a   Silva, Reginaldo M ^b   Franco Penteado, Carla F ^a   Antunes, Edson ^a   Ferreira, Heloisa H A ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b University Sao Francisco   (Brazil)

Author keywords

Allergic rhinitis; Eosinophil chemotaxis; Eotaxin; Fibronectin; Interleukin 5

Indexed keywords

CHEMOKINE; EOTAXIN; INTERLEUKIN 5;

ALLERGIC RHINITIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EOSINOPHIL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NEUTROPHIL CHEMOTAXIS; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION;

CELL ADHESION; CHEMOKINES, CC; CHEMOTAXIS, LEUKOCYTE; EOSINOPHILS; HUMANS; INTERLEUKIN-5; RHINITIS;

EID: 34249025424     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.09.075     Document Type: Article

References (46)

1. Abdelnoor A.M., Kobeissy F., Farhat D., and Hadi U. Some immunological aspects of patients with rhinitis in Lebanon. Immunopharmacol. Immunotoxicol. 24 (2002) 289-301
2. Alexander A.G., Barkans J., Moqbel R., Barnes N.C., Kay A.B., and Corrigan C.J. Serum interleukin-5 concentration in atopic and non-atopic patients with glucocorticoid-dependent chronic severe asthma. Thorax 49 (1994) 1231-1233
3. Anwar A.R., Walsh G.M., Cromwell O., Kay A.B., and Wardlaw A.J. Adhesion to fibronectin primes eosinophils via alpha 4 beta 1 (VLA-4). Immunology 82 (1994) 222-228
4. Braunstahl G.J., Overbeek S.E., Kleinjan A., Prins J.B., Hoogsteden H.C., and Fokkens W.J. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J. Allergy Clin. Immunol. (2001) 469-476
5. Braunstahl G.-J., Fokkens W.J., Overbeek S.E., KleinJan A., Hoogsteden H.C., and Prins J.-B. Mucosal and systemic inflammatory changes in allergic rhinitis and asthma: a comparison between upper and lower airways. Clin. Exp. Allergy 33 (2003) 579-587
6. Broide D., and Sriramarao P. Eosinophil trafficking to sites of allergic inflammation. Immunol. Rev. 179 (2001) 163-172
7. Bruijnzeel P.L., Kuijper P.H., Rihs S., Betz S., Warringa R.A., and Koenderman L. Eosinophil migration in atopic dermatitis. In Increased migratory responses to N-formyl-methionyl-leucyl-phenyl-alanine, neutrophil-activating factor, platelet-activating factor, and platelet factor 4. J. Invest. Dermatol. 100 (1993) 137-141
8. Carlson M., Håkansson L., Kampe M., Stalenheim G., Peterson C., and Venge P. Degranulation of eosinophils from pollen-atopic patients with asthma is increased during pollen season. J. Allergy Clin. Immunol. 89 (1992) 131-139
9. Chiba T., Kamada Y., Saito N., Oyamada H., Ueki S., Kobayashi Y., Kayaba H., and Chihara J. RANTES and eotaxin enhance CD11b and CD18 expression on eosinophils from allergic patients with eosinophilia in the application of whole blood flow cytometry analysis. Int. Arch. Allergy Immunol. 137 Suppl 1 (2005) 12-16
10. Conran N., Ferreira H.H.A., Lorand-Metze I., Thomazzi S.M., Antunes E., and De Nucci G. Nitric oxide regulates human eosinophil adhesion mechanisms in vitro by changing integrin expression and activity on the eosinophil cell surface. Br. J. Pharmacol. 134 (2001) 632-638
11. Corrigan C.J., Haczku A., Gemou-Engesaeth V., Doi S., Kikuchi K., Takatsu S., Durham S.R., and Kay A.B. CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations ot interleukin-5: effect of glucocorticoid therapy. Am. Rev. Respir. Dis. 147 (1993) 540-547
12. Ferreira H.H.A., Lodo M.L.S., Martins A.R., Kandratavicius L., Salaroli A., Conran N., Antunes E., and De Nucci G. Expression of nitric oxide synthases and in vitro migration of eosinophils from allergic rhinitis subjects. Eur. J. Pharmacol. 442 (2002) 155-162
13. Ferreira H.H.A., Costa R.A., Jacheta J.M., Martins A.R., Medeiros M.V., Macedo-Soares M.F., De Luca I.M., Antunes E., and De Nucci G. Modulation of eosinophil migration from bone marrow to lungs of allergic rats by nitric oxide. Biochem. Pharmacol. 68 (2004) 631-639
14. Ferreira H.H.A., Conran N., and Antunes E. Modulation of eosinophil functions by nitric oxide: cyclic GMP-dependent and -independent mechanisms. Anti-Inflamm. Anti-Allergy Agents Med. Chem. 5 (2006) 45-57
15. Foster P.S., Mould A.W., Yang M., Mackenzie J., Mattes J., and Hogan S.P. Elemental signals regulating eosinophil accumulation in the lung. Immunol. Rev. 179 (2001) 173-181
16. Håkansson L., and Venge P. Priming of eosinophil and neutrophil migratory responses by interleukin-3 and interleukin-5. APMIS 102 (1994) 1-7
17. Hanazawa T., Antuni J.D., Kharitonov S.A., and Barnes P.J. Intranasal administration of eotaxin increases nasal eosinophils and nitric oxide in patients with allergic rhinitis. J. Allergy Clin. Immunol. 105 (2000) 58-64
18. Hansel T.T., De Vries I.J., Iff T., Rihs S., Wandzilak M., Betz S., Blaser K., and Walker C. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J. Immunol. Methods 145 (1991) 105-110
19. Jahnz-Ro yk K., Plusa T., and Mierzejewska J. Eotaxin in serum of patients with asthma or chronic obstructive pulmonary disease: relationship with eosinophil cationic protein and lung function. Mediat. Inflamm. 9 (2000) 175-179
20. Kaplan A.P. Chemokines, chemokine receptors and allergy. Int. Arch. Allergy Immunol. 124 (2001) 423-431
21. Kuijpers T.W., Mul E.P., Blom M., Kovach N.L., Gaeta F.C., Tollefson V., Elices M.J., and Harlan J.M. Freezing adhesion molecules in a state of high-avidity binding blocks eosinophil migration. J. Exp. Med. 178 (1993) 279-284
22. Kuna P., Alam R., Ruta U., and Gorski P. RANTES induces nasal mucosal inflammation rich in eosinophils, basophils, and lymphocytes in vivo. Am. J. Respir. Crit. Care Med. 157 (1998) 873-879
23. Lamkhioued B., Renzi P.M., Abi-Younes S., Garcia-Zepada E.A., Allakhverdi Z., Ghaffar O., Rothenberg M.D., Luster A.D., and Hamid Q.J. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. Immunology 159 (1997) 4593-4601
24. Lampinen M., Carlson M., Hakansson L.D., and Venge P. The role of interleukin-5, interleukin-8 and RANTES in the chemotactic attraction of eosinophils to the allergic lung. Clin. Exp. Allergy 29 (1999) 314-322
25. Lampinen M., Carlson M., Håkansson L.D., and Venge P. Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy 59 (2004) 793-805
26. Li L., Xia Y., Nguyen A., Feng L., and Lo D. Th2-induced eotaxin expression and eosinophilia coexist with Th1 responses at the effector stage of lung inflammation. J. Immunol. 161 (1998) 3128-3135
27. Lundahl J., Moshfech A., Grönneberg R., and Halldén G. Eotaxin increases the expression of CD11b/CD18 and adhesion properties in interleukin-5, but not fMLP-prestimulated human peripheral blood eosinophils. Inflammation 22 (1998) 123-135
28. Minshall E.M., Cameron L., Lavigne F., Leung D.Y., Hamilos D., Garcia-Zepada E.A., Rothenberg M., Luster A.D., and Hamid Q. Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis. Am. J. Respir. Cell Mol. Biol. 17 (1997) 683-690
29. Mould A.W., Matthaei K.I., Young I.G., and Foster P.S. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J. Clin. Invest. 99 (1997) 1064-1074
30. Palframan R.T., Collins P.D., Williams T.J., and Rankin S.M. Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. Blood 91 (1998) 2240-2248
31. Quraishi S.A., Davies M.J., and Craig T.J. Inflammatory responses in allergic rhinitis: traditional approaches and novel treatment strategies. JAOA 104 (2004) 7-15
32. Rothenberg M.E. An essential mediator of eosinophil trafficking into mucosal tissues. Am. J. Respir. Cell Med. Biol. 21 (1999) 291-295
33. Sanmugalingham D., De Vries E., Gauntlett R., Symon F.A., Bradding P., and Wardlaw A.J. Interleukin-5 enhances eosinophil adhesion to bronchial epithelial cells. Clin. Exp. Allergy 30 (2000) 255-263
34. Sehmi R., Wardlaw A.J., Cromweell O., Kazuyuki K., Waltmann P., and Kay B. Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. Blood 79 (1992) 2952-2959
35. Shahabuddin S., Ponath P., and Schleimer R.P. Migration of eosinophils across endothelial cell monolayers: interactions among interleukin-5, endothelial-activating cytokines, and C-C chemokines. J. Immunol. 164 (2000) 3847-3854
36. Tachimoto H., Ebisawa M., and Bochner B.S. Cross-talk between integrins and chemokines that influences eosinophil adhesion and migration Int. Arch. Allergy Immunol. 128 (2002) 18-20
37. Tateno H., Nakamura H., Minematsu N., Nakajima T., Takahashi S., Nakamura M., Fukunaga K., Asano K., Lilly C.M., and Yamaguchi K. Plasma eotaxin level and severity of asthma treated with corticosteroid. Respir. Med. 98 (2004) 782-790
38. Teran L.M. CCL chemokines and asthma Immunol. Today 21 (2000) 235-242
39. Till S., Li B., Durham S., Humbert M., Assoufi B., Huston D., Dickason R., Jeannin P., and Kay A.B. Secretion of the eosinophil-active cytokines interleukin-5, granulocyte/macrophage colony-stimulating factor and interleukin-3 by bronchoalveolar lavage CD4+ and CD8+ T cell lines in atopic asthmatics, and atopic and non-atopic controls Eur. J. Immunol. 25 (1995) 2727-2731
40. Walker C., Virchow Jr. J.C., Bruijnzeel P.L., and Blaser K. T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J. Immunol. 146 (1991) 1829-1835
41. Wardlaw A.J. Eosinophil trafficking in asthma. Clin. Med. 1 (2001) 214-218
42. Warringa R.A.J., Mengelers H.J.J., Kuijper P.H.M., Raaijmakers J.A.M., Bruijnzeel P.L., and Koenderman L. In vivo priming of platelet-activating factor-induce eosinophil chemotaxis in allergic asthmatic individuals. Blood 79 (1992) 1836-1841
43. Yamamoto H., Sedgwick J.B., and Busse W.W. Differential regulation of eosinophil adhesion and transmigration by pulmonary microvascular endothelial cells. J. Immunol. 161 (1998) 971-977
44. Yamamoto K., Takanashi S., Hasegawa Y., Kanehira Y., Kaizuka M., and Okumura K. Eotaxin level in induced sputum is increased in patients with bronchial asthma and in smokers. Respiration 70 (2003) 600-605
45. Zimmermann N., and Rothenberg M.E. Receptor internalization is required for eotaxin-induced responses in human eosinophils. J. Allergy Clin. Immunol. 111 (2003) 97-105
46. Zimmermann N., Conkright J.J., and Rothenberg M.E. CC chemokine receptor-3 undergoes prolonged ligand-induced intenalization. J. Biol. Chem. 274 (1999) 12611-12618